Transcriptional analysis of an E2F gene signature as a biomarker of activity of the cyclin-dependent kinase inhibitor PHA-793887 in tumor and skin biopsies from a phase I clinical study

ABSTRACT: Microarray analysis of transcriptional changes in biopsies of solid tumors from patients treated in a Phase I study with the Cdk inhibitor PHA-793887.

ORGANISM(S): Homo sapiens

PROVIDER: GSE18553 | GEO | 2010/05/14

SECONDARY ACCESSION(S): PRJNA121365

REPOSITORIES: GEO